Aarey Drugs & Pharmaceuticals Ltd
06 Nov 2026 12:00 AM
AAREY DRUGS to convene a board meeting November 14 to review financial results,
AAREY DRUGS & PHARMACEUTICALS LIMITED will hold a board meeting on Saturday, November 14, 2026, to approve the unaudited financial results along with a limited review report for the quarter and half year ended September 30, 2026, and to discuss any other business with the consent of the chairman; the trading window for the company has been closed from October 1, 2026, and will remain closed until 48 hours after the announcement of the financial results.
Aarey Drugs & Pharmaceuticals Ltd
08 Oct 2026 12:00 AM
Aarey Drugs receives certificate from MUFG Intime for period ending September 30, 2026,
Aarey Drugs & Pharmaceuticals Limited informed the BSE Limited and National Stock Exchange of India Limited that it has received a certificate from MUFG Intime India Private Limited, formerly Link Intime India Private Limited, under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter and half year ended September 30, 2026.
Aarey Drugs & Pharmaceuticals Ltd
23 Sep 2026 12:00 AM
Aarey Drugs restricts insider trading ahead of September 2026 financial results release,
Aarey Drugs and Pharmaceuticals Limited will close its trading window for insiders, designated persons, and their immediate relatives from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half year ended September 30, 2026, in compliance with SEBI regulations and circulars issued by the BSE and NSE.
Aarey Drugs & Pharmaceuticals Ltd
08 Aug 2026 12:00 AM
Aarey Drugs & Pharmaceuticals announces board meeting date,
Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 August 2026.
Aarey Drugs & Pharmaceuticals Ltd
01 Jun 2026 12:00 AM
Aarey Drugs & Pharmaceuticals standalone net profit rises 231.91% in the March 2026 quarter,
Net profit of Aarey Drugs & Pharmaceuticals rose 231.91% to Rs 1.56 crore in the quarter ended March 2026 as against Rs 0.47 crore during the previous quarter ended March 2025. Sales rose 75.27% to Rs 189.47 crore in the quarter ended March 2026 as against Rs 108.10 crore during the previous quarter ended March 2025.For the full year,net profit declined 1.24% to Rs 3.97 crore in the year ended March 2026 as against Rs 4.02 crore during the previous year ended March 2025. Sales declined 0.35% to Rs 472.27 crore in the year ended March 2026 as against Rs 473.94 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales189.47108.10 75 472.27473.94 0 OPM %2.29-3.89 -1.520.61 - PBDT2.132.04 4 8.268.04 3 PBT1.281.63 -21 5.416.10 -11 NP1.560.47 232 3.974.02 -1 Powered by Capital Market - Live News
Subscribe for our
newsletter
newsletter
HSL Mobile App